Found: 7
Select item for more details and to access through your institution.
Tyrosine kinase inhibitor therapy-induced changes in humoral immunity in patients with chronic myeloid leukemia.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 8, p. 1543, doi. 10.1007/s00432-017-2378-6
- By:
- Publication type:
- Article
Assessment of bone marrow lymphocytic status during tyrosine kinase inhibitor therapy and its relation to therapy response in chronic myeloid leukaemia.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 5, p. 1041, doi. 10.1007/s00432-015-2101-4
- By:
- Publication type:
- Article
Participative Approach to Strategy Communication: A Case of Small- and Medium-Sized Metal Enterprises with a Review after Seven Years.
- Published in:
- Human Factors & Ergonomics in Manufacturing & Service Industries, 2013, v. 23, n. 4, p. 346, doi. 10.1002/hfm.20322
- By:
- Publication type:
- Article
Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8<sup>+</sup> T-cell large granular lymphocytic leukemia.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29173-z
- By:
- Publication type:
- Article
Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease.
- Published in:
- Nature Genetics, 2014, v. 46, n. 8, p. 812, doi. 10.1038/ng.3040
- By:
- Publication type:
- Article
Dominant TOM1 mutation associated with combined immunodeficiency and autoimmune disease.
- Published in:
- NPJ Genomic Medicine, 2019, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41525-019-0088-5
- By:
- Publication type:
- Article
Gemtuzumab-Ozogamicin-Related Impaired Hemoglobin-Haptoglobin Scavenging as On-Target/Off-Tumor Toxicity of Anti-CD33 AML Therapy: A Report of Two Cases.
- Published in:
- Case Reports in Hematology, 2021, p. 1, doi. 10.1155/2021/6641349
- By:
- Publication type:
- Article